Viability PCR – the next level in PCR-based pathogen testing

Supported by:

20 November 2014

Supported by:

20 November 2014

Pharma Webinar: Viability PCR - the next level in PCR-based pathogen testing

Live/dead differentiation of microorganisms helps to ensure safe food production. This pharma webinar introduces viability PCR as a fast and powerful tool to analyze food samples for the presence of potentially harmful microbes. Viability real-time PCR uses the DNA-masking compound propidium monoazide (PMA). PMA enters dead and membrane-compromised pathogen cells and binds to DNA, making the DNA inaccessible to detection by PCR. Live/dead differentiation is important for procedures such as: hygiene testing (success of decontamination processes), water testing (distinguishing between live and dead legionella for regulatory compliance), and several other important applications.

Keynote speaker

Dr. Marcia Armstrong – Global Scientific Affairs Manager, QIAGEN

Dr Marcia Armstrong Qiagen webinarDr. Marcia Armstrong obtained her doctorate in nutrition from the Harvard School of Public Health. After a post-doctoral research fellowship in the Gastroenterology Department at the Brigham and Women’s Hospital, a teaching affiliate of Harvard Medical School, she became an Assistant Professor in the Department of Physiology at the University of Massachusetts Medical School. She has been with QIAGEN for 20 years and is currently Global Scientific Affairs Manager with the food safety testing team.

Supported by QIAGEN

QIAGEN serves more than 500,000 customers around the globe, all seeking insights from the building blocks of life – DNA, RNA and proteins. They deliver Sample to Insight solutions for molecular testing, propelling QIAGEN customers from start to finish to unlock new insights.
Find out more: www.qiagen.com
Learn more about the topic of this webinar: http://www.qiagen.com/gb/landing-pages/detected-dead-or-alive-the-blu-v-way

Related topics


Related organisations